Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 771 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Efficacy and safety of canagliflozin 300 mg in overweight and obese type 2 diabetes mellitus patients in a real-world setting: COLOR study
Pankaj Aneja,Gaurav Bhalla,Neeti Parvesh,Kunal Aneja,Kashish Aneja
Indian Journal of Endocrinology and Metabolism.2019;23(3)307
2Kardiovaskuläre Effekte von SGLT-2-Hemmern
H. Drexel,C. H. Säly
Der Diabetologe.2016;12(3)195
Meng H. Tan,Hussain Alquraini,Kara Mizokami-Stout,Mark MacEachern
Endocrinology and Metabolism Clinics of North America.2016;45(4)819

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal